HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H-J Woerle Selected Research

6- (2- hydroxy- 2- methylpropyl)- 3- (1- (4- (1- methyl- 2- oxo- 1,2- dihydropyridin- 4- yl)phenyl)ethyl)- 6- phenyl- 1,3- oxazinan- 2- one

5/2016Safety, pharmacokinetics and pharmacodynamics of BI 135585, a selective 11β-hydroxysteroid dehydrogenase-1 (HSD1) inhibitor in humans: liver and adipose tissue 11β-HSD1 inhibition after acute and multiple administrations over 2 weeks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H-J Woerle Research Topics

Disease

21Type 2 Diabetes Mellitus (MODY)
05/2016 - 12/2010
7Weight Gain
02/2015 - 01/2011
4Body Weight (Weight, Body)
01/2016 - 01/2011
1Diabetes Mellitus
12/2014
1Weight Loss (Weight Reduction)
12/2012
1Urinary Tract Infections (Urinary Tract Infection)
05/2012
1Cough
05/2012
1Headache (Headaches)
05/2012
1Hypersensitivity (Allergy)
05/2012
1Infections
05/2012
1Nasopharyngitis
05/2012
1Respiratory Tract Infections (Respiratory Tract Infection)
05/2012
1Chronic Kidney Failure (Chronic Renal Failure)
10/2011

Drug/Important Bio-Agent (IBA)

20LinagliptinIBA
01/2016 - 12/2010
10Metformin (Glucophage)FDA LinkGeneric
01/2016 - 12/2010
7Glucose (Dextrose)FDA LinkGeneric
09/2015 - 08/2012
3glimepiride (Amarel)FDA LinkGeneric
03/2015 - 12/2012
2Insulin (Novolin)FDA Link
01/2016 - 09/2015
16- (2- hydroxy- 2- methylpropyl)- 3- (1- (4- (1- methyl- 2- oxo- 1,2- dihydropyridin- 4- yl)phenyl)ethyl)- 6- phenyl- 1,3- oxazinan- 2- oneIBA
05/2016
1Pioglitazone (Actos)FDA Link
12/2014
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2013
1voglibose (Basen)IBA
04/2013
1CreatinineIBA
05/2012
1EnzymesIBA
05/2012
1Pharmaceutical PreparationsIBA
03/2011
1Dipeptidyl-Peptidase IV InhibitorsIBA
12/2010

Therapy/Procedure

7Therapeutics
01/2016 - 12/2010